Metagenomi Therapeutics (MGX) Common Equity (2023 - 2026)
Metagenomi Therapeutics' Common Equity came in at $112.57 million for Q2 2026, down 42.5% from $195.83 million a year earlier and down 18.3% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Common Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Metagenomi Therapeutics' Common Equity was $158.6 million, down 32.5% from FY2024.
- Going back by year, Common Equity was $234.86 million in FY2024 and -$135.58 million in FY2023.
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q4 2023.
- Year-over-year, Common Equity has declined for six consecutive quarters, with an average decline of 31.8% over the last six quarters.
- Business Quant data shows MGX's Common Equity at $137.79 million (Q1 2026), $158.6 million (Q4 2025) and $178.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Metagenomi Therapeutics | 42.69 Mn | 42.69 Mn | - | 112.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.57 Mn |
| Mar 31, 2026 | 137.79 Mn |
| Dec 31, 2025 | 158.60 Mn |
| Sep 30, 2025 | 178.45 Mn |
| Jun 30, 2025 | 195.83 Mn |
| Mar 31, 2025 | 212.66 Mn |
| Dec 31, 2024 | 234.86 Mn |
| Sep 30, 2024 | 255.77 Mn |
| Jun 30, 2024 | 269.42 Mn |
| Mar 31, 2024 | 275.63 Mn |
| Dec 31, 2023 | -135.58 Mn |
| Sep 30, 2023 | -119,021.00 |
| Jun 30, 2023 | -102.54 Mn |
| Mar 31, 2023 | -90.01 Mn |
API Access
Metagenomi Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();